FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
August 11, 2023 2 min read Source/Disclosures Disclosures: Collins reports receiving honoraria from Curio Sciences during the conduct of the
Read MoreA building on the campus at the world headquarters of Illumina is shown in San Diego, California, Sept. 1, 2021.
Read MoreAugust 11, 2023 3 min read Source/Disclosures Published by: Source: Healio Interviews Disclosures: Li reports consulting for AbbVie and receiving
Read MoreAt the Alzheimer’s Association International Conference 2023, several studies on the use of blood tests for the diagnosis and treatment
Read MoreAugust 10, 2023 3 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO
Read MoreAn aerial view of a wildfire in Kihei, Maui County, Hawaii, U.S., August 8, 2023 in this screen grab obtained
Read MoreAugust 10, 2023 3 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read MoreEl sistema de seguro médico de la nación está en plena convulsión: cerca de 8,2 millones de personas necesitan encontrar
Read MoreSANTA CRUZ, Calif. — From an early age, Pasha Wrangell felt different. Societal expectations of boys, and many characteristics of
Read MoreAugust 09, 2023 2 min read Source/Disclosures Disclosures: Witonsky reports no relevant financial disclosures. Please see the full study for
Read More